Related Articles for PubMed (Select 18269690)

Recombinant human activated protein C: current insights into its mechanism of action.

Levi M, van der Poll T.

Crit Care. 2007;11 Suppl 5:S3. Review.

PMID: 18269690 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.

Dhainaut JF, Yan SB, Cariou A, Mira JP.

Crit Care Med. 2002 May;30(5 Suppl):S318-24. Review.

PMID: 12004254 [PubMed - indexed for MEDLINE]

Coagulopathy and the role of recombinant human activated protein C in sepsis and following polytrauma.

Dahabreh Z, Dimitriou R, Chalidis B, Giannoudis PV.

Expert Opin Drug Saf. 2006 Jan;5(1):67-82. Review. Erratum in: Expert Opin Drug Saf. 2006 Mar;5(2):345.

PMID: 16370957 [PubMed - indexed for MEDLINE]

[Activated protein C, coagulation, inflammation, and treatment of severe sepsis]

van Deventer SJ, Pajkrt D.

Ned Tijdschr Geneeskd. 2001 Mar 31;145(13):613-6. Review. Dutch.

PMID: 11305209 [PubMed - indexed for MEDLINE]

Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness.

Haley M, Cui X, Minneci PC, Deans KJ, Natanson C, Eichacker PQ.

Curr Opin Infect Dis. 2004 Jun;17(3):205-11. Review.

PMID: 15166822 [PubMed - indexed for MEDLINE]

[Novel treatment for severe sepsis: recombinant human protein C (RHAPC)]

Uszyiński W, Uszyński M, Lisiecki A.

Ginekol Pol. 2005 Nov;76(11):913-20. Review. Polish.

PMID: 16566369 [PubMed - indexed for MEDLINE]

10:

Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.

Derhaschnig U, Reiter R, Knöbl P, Baumgartner M, Keen P, Jilma B.

Blood. 2003 Sep 15;102(6):2093-8. Epub 2003 May 15.

PMID: 12750166 [PubMed - indexed for MEDLINE]

11:

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.

Esmon CT.

Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2. Review.

PMID: 11445734 [PubMed - indexed for MEDLINE]

12:

Recombinant human activated protein C in severe sepsis.

Mann HJ.

Am J Health Syst Pharm. 2002 Feb 15;59 Suppl 1:S19-23. Review.

PMID: 11885409 [PubMed - indexed for MEDLINE]

13:

Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.

Koestenberger M, Cvirn G, Gallistl S, Muntean W.

Blood Coagul Fibrinolysis. 2004 Oct;15(8):693-7.

PMID: 15613925 [PubMed - indexed for MEDLINE]

14:

New and emerging therapies for sepsis.

Healy DP.

Ann Pharmacother. 2002 Apr;36(4):648-54. Review.

PMID: 11918516 [PubMed - indexed for MEDLINE]

15:

Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure.

Brueckmann M, Wizenmann J, Hoffmann U, Seeger M, Bewig B.

Thromb Res. 2003 Mar 15;109(5-6):259-63.

PMID: 12818248 [PubMed - indexed for MEDLINE]

16:

Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis.

Maybauer MO, Maybauer DM, Fraser JF, Traber LD, Westphal M, Enkhbaatar P, Cox RA, Huda R, Hawkins HK, Morita N, Murakami K, Mizutani A, Herndon DN, Traber DL.

Crit Care Med. 2006 Sep;34(9):2432-8.

PMID: 16810106 [PubMed - indexed for MEDLINE]

17:

Drotrecogin alfa (recombinant human activated protein C) for the treatment of severe sepsis.

McCoy C, Matthews SJ.

Clin Ther. 2003 Feb;25(2):396-421. Review.

PMID: 12749504 [PubMed - indexed for MEDLINE]

18:

Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.

Robriquet L, Collet F, Tournoys A, Prangère T, Nevière R, Fourrier F, Guery BP.

Respir Res. 2006 Mar 22;7:41.

PMID: 16553944 [PubMed - indexed for MEDLINE]

Recent Activity